Both in Biotechnology
Attovia Therapeutics vs Ginkgo Bioworks Holdings
Over the past year ATTO returned −34.0% and DNA returned +45.9%; their daily moves had a correlation of 0.47.
ATTO −34.0% DNA +45.9%Growth of $1, one year, split-adjusted
| Metric | ATTO | DNA |
|---|---|---|
| Price | $15.05 | $9.85 |
| Market cap | $687.1M | $663.3M |
| Today | −0.92% | −12.13% |
| 1 month | −12.3% | −20.2% |
| 6 months | — | −0.6% |
| Year to date | — | +18.5% |
| 1 year | — | −18.0% |
| Revenue growth (YoY) | — | −48.5% |
| Gross margin | — | 91.5% |
| Net margin | — | −231.7% |
| P/E (TTM) | — | — |
| Price / sales | — | 5.9× |
| Net cash | — | $302.2M |
| Dividend yield | — | — |
| Volatility (60d) | — | 127.4% |
| Short % of float | 5.6% | 18.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).